Chronic myelogenous leukemia after postoperative adjuvant S-1 therapy for rectal cancer: a case report

American Journal of Blood Research

Junya Okita¹  Naonori Harada¹  Kazuhiro Takeuchi¹  Yoshio Furukawa¹  Masahiro Manabe¹  Takeo Kumura¹  Johji Nagasaki¹  Atsuko Mugitani¹  Takafumi Nishii¹  Yasutaka Aoyama¹  Tadanobu Ohta¹ 

关键词: Chronic myelogenous leukemia;    rectal cancer;    fluoropyrimidine;    S-1;   

DOI  :  

学科分类：血液学

来源: e-Century Publishing Corporation

【 摘 要 】

We report a case in which chronic myelogenous leukemia (CML) developed after postoperative adjuvant S-1 therapy for rectal cancer. A 56-year-old man was diagnosed with rectal adenocarcinoma, which was treated with abdominoperineal resection followed by a year of adjuvant S-1 therapy. At 39 postoperative months, he was diagnosed with CML. Although it remains unclear that CML that develops after treatment involving cytotoxic agents is treatment-related, clinicians should be aware of the possibility of CML developing after S-1 therapy.

【 授权许可】

Unknown